Dr. Ali R. Moosvi, MD

Dr. Moosvi practices at Shore Cardiology Consultants in Brick, New Jersey.

Dr. Moosvi's NPI, 1093796948, was assigned on November 8, 2005. Dr. Moosvi holds New Jersey license 25MA05586800.

Dr. Moosvi's primary practice is Shore Cardiology Consultants, at 1640 State Highway 88, Brick, NJ 08724 in Ocean County. The practice phone is (732) 840-1900.

Dr. Moosvi's primary practice is Shore Cardiology Consultants in Brick, New Jersey. Dr. Moosvi is also affiliated with Ocean University Medical Center. The medical group on file is Shore Cardiology Consultants. Dmand AI also links Dr. Moosvi to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moosvi practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Moosvi's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Moosvi is licensed in New Jersey.

CMS data shows 6,859 Medicare services from Dr. Moosvi across 21 procedure codes in 2024, for 1,953 Medicare patients. Medicare paid $585,700 for them.

CMS counts 1,953 Medicare patients who saw Dr. Moosvi in 2024. The largest group is 75 to 84, with 772 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moosvi's median patient age at 72, with 47% women.

In 2024, Dr. Moosvi wrote 7,695 Medicare Part D claims for 1,143 patients. 85% of them were for generic drugs. CMS names the drug for 7,380 of them, across 63 drugs with 11 or more claims each, at $1,249,963 in total drug cost. In 2023, CMS named 6,681 claims across 61 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Moosvi for performance year 2024, reported as part of a group. Dr. Moosvi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 19 procedures of coronary angioplasty and stenting by Dr. Moosvi, more than 48% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Moosvi in 2022. Dr. Moosvi's most frequent co-authors are Cindy Cai, MD and Ross Dennis Zafonte, DO.

CMS Open Payments shows 557 general payments to Dr. Moosvi from 64 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. Janssen Research & Development, LLC paid the most, $1,615.